Friday, March 29, 2024
Technology News
Trusted, Accurate, and Validated
Home / Business  / Biological Crop Company Closes $15.9 Million Series B

Biological Crop Company Closes $15.9 Million Series B

Biological Crop Company Closes $15.9 Million Series B
Credit: inocucor.com

Inocucor Corporation, a developer and producer of biological crop inputs for high-value produce and row crops, completed the final close of its Series B funding round at $15.9 million, with participation by existing investors Cycle Capital Management (Montreal), Desjardins Innovatech (Montreal), TPG ART (San Francisco), and Pontifax AgTech (Los Angeles).

Inocucor’s President and CEO, Donald R. Marvin, plans to use the funds to develop a new class of crop inputs that combine the company’s biologicals with ATP’s plant nutrients for canola, corn, soybean and other broadacre crops, as well as high-value produce markets.

The company’s new 30,000-square-foot U.S. headquarters and commercialization office is currently under construction in Centennial, Colorado. Its Montreal-based, R&D-focused Technical Center of Excellence was recently expanded from 10,000 to 20,000 square feet. Inocucor employs about 65 people in Canada and the U.S., and anticipates adding another 25 to 30 high-level scientific and managerial professionals over the next year.